Prevention of Future Deaths reports · 2020
Regulation 28 report to prevent future deaths, reference 2020-0163, written 18 Aug 2020. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.
| Date of report | 18 Aug 2020 |
|---|---|
| Reference | 2020-0163 |
| Deceased | Viktor Scott-Brown |
| Coroner | Oliver Longstaff |
| Coroner area | County Durham and Darlington |
| Category | Suicide (from 2015) · Community health care |
| Organisation named | Oxleas NHS Foundation Trust · South London and Maudsley NHS Foundation Trust · Tees, Esk and Wear Valleys NHS Foundation Trust |
| Source | judiciary.uk record · original PDF |
| Responses published | 4 |
Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.
Regulation 28: AMENDED REPORT TO PREVENT FUTURE DEATHS (1) NOTE: This form is to be used after an inquest. REGULATION 28 REPORT TO PREVENT DEATHS THIS REPORT IS BEING SENT TO: 1 National Institute for Health and Clinical Excellence 2 The South London and Maudsley NHS Foundation Trust 3 Oxleas NHS Foundation Trust 4 5 Tees, Esk and Wear Valleys NHS Foundation Trust Informa Healthcare 1 CORONER I am Oliver Robert Longstaff, HM Assistant Coroner for the area of County Durham and Darlington. 2 CORONER’S LEGAL POWERS I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 2009 and regulations 28 and 29 of the Coroners (Investigations) Regulations 2013. 3 INVESTIGATION and INQUEST On 20th December 2018 I commenced an investigation into the death of Viktor John Anthony SCOTT- BROWN aged 23. The investigation concluded at the end of the inquest on 12th August 2020. The conclusion of the inquest was that the death was a suicide. The medically certified cause of death was:- I a Hanging 4 CIRCUMSTANCES OF THE DEATH Viktor John Anthony Scott-Brown was found hanging at his home address overnight on the 14th/15th December 2018 and pronounced dead at the scene. There were no suspicious circumstances. He had recently been prescribed Lamotrigine but had not been warned that use of that medication carries a risk of causing thoughts of self harm or suicide, and his taking of that medication was not monitored accordingly. Had he been informed of that risk, he would have sought medical assistance when he began to experience thoughts of self harm and suicide, and it is unlikely he would have taken his life when he did. 5 CORONER’S CONCERNS The MATTERS OF CONCERNS are as follows: Mr Scott-Brown was prescribed Lamotrigine by an NHS Foundation Trust Consultant Psychiatrist. The prescribing consultant did not give Mr Scott-Brown a Trust information sheet about Lamotrigine and a Patient Information Leaflet about Lamotrigine from the drug manufacturer, GlaxoSmithKline. It was common ground that the consultant should have done so. Both documents record as a side effect of using Lamotrigine a risk that the patient may begin to experience thoughts of self-harm or suicide. Mr Scott-Brown was never given that information. The consultant gave evidence that he was not aware of that particular side effect of Lamotrigine, and that his prescribing practice was informed by the British National Formulary and The Maudsley Prescribing Guidelines. Neither the online BNF viewable via the NICE website nor the 10th Edition of The Maudsley Guidelines (to which the court was referred) refer to that side effect in their respective entries for Lamotrigine. Subsequent to the conclusion of the Inquest, I have learned from the Oxleas NHS Foundation Trust that when Mr Scott-Brown was prescribed Lamotrigine, the then current edition of the Maudsley Guidelines was the 13th Edition. The Inquest heard no evidence about the 13th Edition of the Maudsley Guidelines and information therein concerning Lamotrigine. Quite apart from any issue regarding the consultant’s knowledge about Lamotrigine (and the existence of the 13th Edition of the Maudsley Guidelines) and his not having given Mr Scott-Brown the Trust’s prepared information about the drug and its side effects, I am concerned that two obviously reputable sources of pharmacological information are apparently silent, or have been silent, on a potentially significant side effect of this particular drug. From a lay perspective, there is apparent potential for harm to patients depending upon which resources a prescriber consults before prescribing Lamotrigine. That potential for harm might be ameliorated were the advice about Lamotrigine consistent across all such resources. 6 ACTION SHOULD BE TAKEN In my opinion action should be taken to prevent future deaths and I believe your organisation has the power to take such action. In the case of NICE, that power arises from the BNF being a resource accessible on the NICE website. In the case of The South London and Maudsley NHS Foundation Trust and the Oxleas NHS Foundation Trust, that power arises from the credited authors and editors of The Maudsley Prescribing Guidelines (10th Edition) being in post within those Trusts respectively. In the case of Informa Healthcare, that power arises from that corporate entity being the publisher of The Maudsley Prescribing Guidelines. In the case of the Tees, Esk and Wear Valleys NHS Foundation Trust, that power arises from the Trust being in a position to ensure that its prescribers work with reference to the up to date edition of any resource upon which they rely for prescribing guidance. 7 YOUR RESPONSE You are under a duty to respond to this report within 56 days of the date of this report, namely by 20th October 2020. I, the coroner, may extend the period. Your response must contain details of action taken or proposed to be taken, setting out the timetable for action. Otherwise you must explain why no action is proposed. 8 COPIES and PUBLICATION I have sent a copy of my report to the Chief Coroner and to the following Interested Persons The next of kin of Viktor John Anthony Scott-Brown I am also under a duty to send the Chief Coroner a copy of your response. The Chief Coroner may publish either or both in a complete or redacted or summary form. He may send a copy of this report to any person who he believes may find it useful or of interest. You may make representations to me, the coroner, at the time of your response about the release or the publication of your response by the Chief Coroner. 9 «AuthorisingUserSignature» «AuthorisingUserFullName» «AuthorisingUserAppointment» for «AuthorisingUserJurisdiction» Dated: «AuthorisedDateDayFirstLong»
4 responses published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.
BNF Publications bnf.org ________________________________________________________________________________ Mr Longstaff H.M. Coroners Office PO Box 282 Bishop Auckland Co Durham DL14 4FY cc: 30th September 2020 Dear Mr Longstaff, @nice.org.uk), @nice.org.uk) @nice.org.uk), We write in response to your letter to NICE dated 18th August 2020 (ref: 02705-2018). Your letter was forwarded to us as the Publisher of the British National Formulary. We are sorry to hear the sad circumstances surrounding this case. We have reviewed the BNF content for lamotrigine in response to your letter and can confirm that we will add a side-effect of suicidal ideation to the lamotrigine monograph in the BNF. We will also add information on this side-effect to the important safety section of the lamotrigine monograph. This will mean that the risk of suicidal thoughts and behaviour will be highlighted in the lamotrigine monograph in future. We trust that this addresses this important issue Yours sincerely, Associate Content Director (BNF Publications) ________________________________________________________________________________ Royal Pharmaceutical Society 66-68 East Smithfield, London E1W 1AW
22 September 2020 Oliver Longstaff H M Assistant Coroner H.M. Coroner’s Office PO Box 282 Bishop Auckland Co Durham DL14 4FY Your ref: 02705-2018 Our ref: EH-309378 Dear Mr Longstaff, I write in response to your Regulation 28: Report to Prevent Future Deaths, dated 18 August 2020, regarding the tragic death of Viktor John Anthony Scott-Brown. We have considered the circumstances surrounding Mr Scott-Brown’s death and the concerns raised in the report regarding the content of the British National Formulary (BNF). Namely, that the BNF information regarding lamotrigine should be updated to mention possible risks of self-harm, and suicidal thoughts and behaviour. Although accessible from the NICE website, the BNF is a joint publication of the British Medical Association and the Royal Pharmaceutical Society. NICE manages the contract for the production of the BNF and BNF for Children (BNFC), but has no role in reviewing their content. Your concerns have therefore been passed to the BNF publishers, in confidence, for their consideration and action, as appropriate. They have confirmed they will respond to the Regulation 28: Report directly to you, copying NICE into their response. The concerns in your report have also been considered by NICE’s Centre for Guidelines, with regards to our guideline on epilepsies: diagnosis and management (CG137). This guideline contains the following recommendation and footnote: 1.9.17 Continuation of pharmacological treatment 1.9.17.1 Maintain a high level of vigilance for treatment-emergent adverse effects (for example, bone health issues and neuropsychiatric issues[16]). [16] Treatment with AEDs is associated with a small risk of suicidal thoughts and behaviour; available data suggest that the increased risk applies to all AEDs and may be seen as early as 1 week after starting treatment. The guideline is currently in the process of being updated. Given that the guideline update is not due to publish for some time we will consider the concerns of the coroner’s report – including, the appropriateness of moving the footnote into the recommendation. Yours sincerely, Professor Chief Executive
20 August 2020 Mr Oliver Longstaff HM Assistant Coroner for County Durham and Darlington HM Coroner’s Office PO Box 282 Bishop Auckland Co Durham DL14 4FY Oxleas NHS Foundation Trust Pinewood House Pinewood Place Dartford Kent DA2 7WG 01322 625700 oxleas.nhs.uk Sent by email to: Dear Mr Longstaff Re: Viktor John Anthony Scott-Brown, deceased We write in response to your Regulation 28 Report dated 18 August 2020 and your letter dated 19 August 2020. Oxleas NHS Foundation Trust no longer has any involvement in the authorship or editing of the Maudsley Prescribing Guidelines. Our last involvement was in April 2015, when the 12th edition was published. The most recent version, the 13th edition, was published in May 2018, and cited a new team of editors, which did not include Oxleas NHS Foundation Trust. Oxleas NHS Foundation Trust is therefore not in a position to influence the content of future iterations of the Maudsley Prescribing Guidelines. We trust that this provides a satisfactory response, but if you have any further queries, please do contact us via oxl-tr.legalservices@nhs.net. Yours sincerely Deputy Medical Director
Executive Suite West Park Hospital Edward Pease Way Darlington Co Durham DL2 2TS Direct line Fax No. E-mail: 15 September 2020 Mr Longstaff H M Assistant Coroner for County Durham and Darlington H M Coroners Office PO Box 282 Bishop Auckland Co Durham DL14 4FY Dear Mr Longstaff Re: Viktor John Anthony Scott-Brown Regulation 28 Report Further to your letter of 25 August 2020, I write to detail the actions the Trust is taking to address the concerns you identified during the inquest into Viktor John Anthony Scott-Brown’s death. In particular the Trust was to ensure that its prescribers work with reference to the up to date edition of any resource upon which they rely for prescribing guidance. I would like to reassure you that as an organisation we have taken your concerns seriously. As a consequence we have committed to develop a Medication Safety Series document regarding prescribing resources and sources of patient information. This will be made available to all prescribers. We are aiming to have a draft ready for approval at our Drugs and Therapeutics Committee on 24th September 2020. The final document will then be provided to all prescribers and other relevant staff within the Trust. This is expected to be completed by 2nd October 2020. In addition further communication on this will be provided widely through the Trust Ebulletin. It will also be available on the Trust intranet. I trust this provides you with the reassurance you required that we are taking appropriate action to address your concerns. However, should you require any further information please do not hesitate to contact me. Yours sincerely, Chief Executive ______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ Trust headquarters West Park Hospital, Edward Pease Way, Darlington, DL2 2TS
See every Prevention of Future Deaths report matching Oxleas NHS Foundation Trust, and how often a new one appears.
What would an alert for this have sent me? Search the full text
Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.
These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.